2 recruiting, 1 completed, 1 not yet recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Biliary Tract Cancer (CCA): new trials by email Literature Review of Biliary Tract Cancer (CCA) trials Research Report on Biliary Tract Cancer (CCA)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRACE-BTC. Relation of Biomarkers and Patients Reported Quality of Life to Outcomes in Patients With Biliary Tract Cancer: a Real- World Cohort Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA) | Not yet recruiting | Aarhus University Hospital | 300 | 2026-03-15 | 2026-03-06 | |
| In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers Biliary Tract Cancer (BTC), Biliary Tract Cancer (CCA) | Recruiting | University of Nottingham | 160 | 2026-01-25 | 2026-04-29 | |
| A Single-arm, Multicenter, Exploratory Study of Adebrelimab Combined With Apatinib and Systemic Chemotherapy for Initially Unresectable Biliary Tract Cancer Adebrelimab combined with the GC regimen and Apatinib - Biliary Tract Cancer, Biliary Tract Cancer (CCA) | Phase 2 | Recruiting | Yongjun Chen | 37 | 2025-08-14 | 2025-08-22 |
| Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tract Cancer Durvalumab, Tremelimumab, Capecitabine - Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma | Phase 2 | Completed | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 40 | 2022-05-23 | 2025-05-01 |
Biliary Tract Neoplasms (4) · Cholangiocarcinoma (3) · Gallbladder Neoplasms (2) · Klatskin Tumor (2) · Neoplasm, Residual (1) · Neoplasms (1) · Pancreatic Cyst (1) · Pancreatic Neoplasms (1)
Biliary Tract Diseases (4) · Digestive System Diseases (4) · Digestive System Neoplasms (4) · Neoplasms by Site (4) · Adenocarcinoma (3) · Carcinoma (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Gallbladder Diseases (2) · Cysts (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Neoplastic Processes (1) · Pancreatic Diseases (1)
Capecitabine (1) · apatinib (1) · durvalumab (1) · tremelimumab (1)
Aarhus University Hospital (1) · Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1) · University of Nottingham (1) · Yongjun Chen (1)
China (1) · Denmark (1) · Germany (1) · United Kingdom (1)
Guruprasad P Aithal, MBBS, MD, PhD (1) · Karen-Lise Garm Spindler, Professor, MD, PhD (1) · Lise Thorsen, Associate professor, MD, PhD (1) · Mohamed Metwally, Consultant, MD, PhD (1) · Salah Al-Batran, Prof. Dr. (1)